-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 22, Sinopharm Modern issued an announcement stating that the company and its wholly-owned subsidiary Sinogong Co.
, Ltd.
respectively received the "Approval Notice for Supplementary Drug Application" approved and issued by the State Drug Administration, and approved nifedipine controlled-release tablets (30mg).
) and omeprazole enteric-coated tablets (20mg) were evaluated by the consistency of generic drug quality and efficacy
.
1.
Nifedipine Controlled Release Tablets
Nifedipine Controlled Release Tablets
Nifedipine is mainly used for the treatment of hypertension and coronary heart disease (chronic stable angina)
.
Nifedipine controlled-release tablets use the membrane-regulated push-pull osmotic pump principle, and the drug is released at a zero-order rate, which can effectively improve the "peak and valley" phenomenon of blood drug concentration.
According to the Minet database, the sales of nifedipine controlled-release tablets in 2020 in public hospitals nationwide will be approximately RMB 2.
177 billion
.
The sales revenue of the company's nifedipine controlled-release tablets in 2020 is approximately RMB 1.
According to the CDE website, the companies that have passed or are deemed to have passed the consistency evaluation of nifedipine controlled-release tablets include Beijing Honglin Pharmaceutical Co.
, Ltd.
and Guangzhou Yipinhong Pharmaceutical Co.
,
Ltd.
Up to now, the company has invested about RMB 28.
2.
Omeprazole enteric-coated tablets
Omeprazole enteric-coated tablets
Omeprazole is mainly used for the treatment of duodenal ulcer, Zollinger-Ellison syndrome (gastrinoma), gastric ulcer and reflux esophagitis, etc.
It can also be combined with amoxicillin and clindamycin or with Metronidazole is used in combination with clarithromycin to kill Helicobacter pylori
.
According to the data from the PDB Drug Comprehensive Database, the sales of omeprazole enteric-coated tablets in domestic sample hospitals in the past three years were RMB 62.
9499 million
.
In the past three years, the sales revenue of omeprazole enteric-coated tablets of Guogong Co.
According to the CDE website, there are currently Hunan Fangsheng Pharmaceutical Co.
, Ltd.
and Shandong New Times Pharmaceutical Co.
, Ltd.
that have passed or are deemed to pass the consistency evaluation of omeprazole enteric-coated tablets
.
Up to now, Guogong Co.
